Search results
GOLD works with healthcare professionals and public health officials around the world to raise awareness of COPD and to improve prevention and treatment of this lung disease.
GLOBAL STRATEGY FOR PREVENTION, DIAGNOSIS AND MANAGEMENT OF COPD: 2023 Report. Evidence-based strategy document for COPD diagnosis, management, and prevention, with citations from the scientific literature.
20 de dic. de 2021 · The Global Initiative for Chronic Obstructive Lung Disease (GOLD) scientific committee has published their 2022 update of the Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease report.
GOLD COPD report: 2023 update. On Nov 14, 2022, the Global Initiative for Chronic Obstructive Lung Disease (GOLD) published their 2023 global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease (COPD).
GOLD COPD report: 2023 update. On Nov 14, 2022, the Global Initiative for Chronic Obstructive Lung Disease (GOLD) published their 2023 global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease (COPD).
GOLD 2023 defines COPD as a heterogeneous lung condition characterized by chronic respiratory symptoms (dyspnea, cough, expectoration and/or exacerbations) due to abnormalities of the airways (bronchitis, bronchiolitis) and/or alveoli (emphysema) that cause persistent, often progressive, airflow obstruction.
1 de abr. de 2023 · Executive summary of the Global Strategy for Prevention, Diagnosis and Management of COPD 2023: the latest evidence-based strategy document from the Global Initiative for Chronic Obstructive Lung Disease (GOLD) https://bit.ly/3KCaTGe.
